Calretinin, CD34, and α-smooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary
Authors:
Open Access
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 19 (3) , 364-372
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: Workshop perspectivesHuman Pathology, 2004
- CD34 + fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteriVirchows Archiv, 2002
- Serous Borderline Tumors of the OvaryAmerican Journal of Surgical Pathology, 2002
- Refined Diagnostic Criteria for Implants Associated With Ovarian Atypical Proliferative Serous Tumors (Borderline) and Micropapillary Serous CarcinomasAmerican Journal of Surgical Pathology, 2001
- Ovarian serous borderline tumors: A critical review of the literature with emphasis on prognostic indicatorsHuman Pathology, 2000
- Immunoreactivity for the Human Hematopoietic Progenitor Cell Antigen (CD34) in Lipomatous TumorsAmerican Journal of Surgical Pathology, 1997
- Calretinin: A Novel Immunocytochemical Marker for MesotheliomaAmerican Journal of Surgical Pathology, 1996
- The Calcium Binding Protein Calretinin is a Selective Marker for Malignant Pleural Mesotheliomas of the Epithelial TypePathology - Research and Practice, 1996
- Peritoneal implants of ovarian serous borderline tumors: Histologic features and prognosisCancer, 1988
- Classification and Staging of Malignant Tumours in the Female PelvisActa Obstetricia et Gynecologica Scandinavica, 1971